US State Regulatory Approvals Update | 23-Mar-2023 | 07:00 | RNS |
First Mevalone authorisation for domestic use | 30-Jan-2023 | 07:00 | RNS |
Trading Update | 10-Jan-2023 | 07:00 | RNS |
Distribution Agreement for Mevalone in France | 15-Dec-2022 | 07:00 | RNS |
Organic Certification in Greece | 30-Nov-2022 | 07:00 | RNS |
AIM Rule 17 Notification | 24-Oct-2022 | 12:00 | RNS |
Holding(s) in Company | 03-Oct-2022 | 16:39 | RNS |
Eden Half Yearly Report | 30-Sep-2022 | 07:00 | RNS |
Appointment of Auditor | 28-Sep-2022 | 08:46 | RNS |
Eden granted US EPA regulatory approval | 26-Sep-2022 | 07:00 | RNS |
Appointment of Non-Executive Director | 02-Sep-2022 | 07:00 | RNS |
Trading Update | 22-Aug-2022 | 07:00 | RNS |
Exercise of Options | 07-Jul-2022 | 07:00 | RNS |
Result of AGM | 29-Jun-2022 | 12:18 | RNS |
AGM Statement | 29-Jun-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 3.33p |
Change Today | -0.042p |
% Change | -1.23 % |
52 Week High | 6.40 |
52 Week Low | 3.33 |
Volume | 64,052 |
Shares Issued | 380.86m |
Market Cap | £12.70m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
10:15 | 14,052 @ 3.45p |
09:48 | 50,000 @ 3.50p |
CFO | Alexander John Abrey |
CEO | Sean M. Smith |
You are here: research